iShares Biotechnology ETF $IBB Stock Holdings Lifted by Leuthold Group LLC

Leuthold Group LLC raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 41.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 18,188 shares of the financial services provider’s stock after buying an additional 5,285 shares during the quarter. Leuthold Group LLC’s holdings in iShares Biotechnology ETF were worth $3,070,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the second quarter valued at about $25,000. Cornerstone Planning Group LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter valued at about $35,000. Strategic Wealth Advisors LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter valued at about $35,000. Parkside Financial Bank & Trust grew its stake in iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 87 shares in the last quarter. Finally, Close Asset Management Ltd grew its stake in iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after purchasing an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $166.83 on Monday. The business’s 50-day moving average price is $169.24 and its two-hundred day moving average price is $169.66. iShares Biotechnology ETF has a one year low of $118.51 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.